News

SHOREmap could also be applied to mapping of quantitative trait loci, large deletions and recessive lethal or dominant mutations (Supplementary Note).
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the most promising stocks according to Wall Street analysts. On June 23, Revolution Medicines announced that the US FDA granted Breakthrough Therapy ...
“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...
A new breast cancer vaccine shows significant promise in preventing and treating the disease, particularly triple-negative ...
In August 2023, this American child, whom we will call J., was doing well. He was playing sports and leading a normal life.
NanoViricides, Inc. is a publicly traded clinical-stage company focused on creating special purpose nanomaterials for antiviral therapy. The company's innovative nanoviricide class of drug candidates ...
Landmark research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why ...
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...
Molecules that build coenzyme Q10, vital for mitochondrial function, healed mice and a patient with an ultra-rare and lethal ...